Mizuho Raises PT to $194 from $184, Maintains Outperform on Tenet.

Mizuho Raises PT to $194 from $184, Maintains Outperform on Tenet.

Mizuho Financial Group has updated its price target for Tenet Healthcare Corporation (THC) to $194, an increase from the previous target of $184. The firm maintains its "outperform" rating on the healthcare services provider, reflecting a positive outlook on the company's financial performance and growth prospects.

The revision in the price target comes amidst a broader review of analyst ratings and price targets for several U.S.-listed companies. Analysts have been adjusting their valuations and expectations based on recent earnings reports and market conditions. For instance, Macquarie Group has revised its rating for Core Scientific Inc (CORZ.O) from "surperform" to "neutral," while Stifel Financial has increased the price target for Starbucks Corporation (SBUX.O) from $92 to $105.

Mizuho's upgrade for Tenet Healthcare suggests that the firm sees significant upside potential in the company's stock. This positive sentiment is likely driven by Tenet's strong financial results and its strategic positioning in the healthcare services sector.

The recent changes in analyst ratings and price targets highlight the dynamic nature of the stock market and the importance of staying informed about the latest developments in the financial world.

References:
[1] https://www.boursorama.com/bourse/actualites/tour-d-horizon-de-la-recherche-aux-etats-unis-core-scientific-phillips-66-starbucks-9983970f8a6acc3ae16d03b8dce4f986